HK1204559A1 - Solid composition of amino carboxylate salt - Google Patents

Solid composition of amino carboxylate salt

Info

Publication number
HK1204559A1
HK1204559A1 HK15105091.0A HK15105091A HK1204559A1 HK 1204559 A1 HK1204559 A1 HK 1204559A1 HK 15105091 A HK15105091 A HK 15105091A HK 1204559 A1 HK1204559 A1 HK 1204559A1
Authority
HK
Hong Kong
Prior art keywords
solid composition
carboxylate salt
amino carboxylate
amino
salt
Prior art date
Application number
HK15105091.0A
Other languages
English (en)
Chinese (zh)
Inventor
Shinichiro Tajiri
Masami Takemura
Shinji Yoshinaga
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of HK1204559A1 publication Critical patent/HK1204559A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK15105091.0A 2013-04-04 2015-05-28 Solid composition of amino carboxylate salt HK1204559A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013079006 2013-04-04
PCT/JP2014/059812 WO2014163132A1 (fr) 2013-04-04 2014-04-03 Composition solide de sel d'amino carboxylate

Publications (1)

Publication Number Publication Date
HK1204559A1 true HK1204559A1 (en) 2015-11-27

Family

ID=51658423

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105091.0A HK1204559A1 (en) 2013-04-04 2015-05-28 Solid composition of amino carboxylate salt

Country Status (12)

Country Link
US (1) US9675570B2 (fr)
EP (1) EP2826477B1 (fr)
JP (1) JP5627062B1 (fr)
KR (1) KR102142257B1 (fr)
CN (1) CN104334169B (fr)
BR (1) BR112014029538B1 (fr)
CA (1) CA2870675C (fr)
ES (1) ES2638420T3 (fr)
HK (1) HK1204559A1 (fr)
IN (1) IN2014MN02116A (fr)
TW (1) TWI645863B (fr)
WO (1) WO2014163132A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3437639A1 (fr) 2015-03-19 2019-02-06 Daiichi Sankyo Company, Limited Préparation solide contenant un colorant
US10561628B2 (en) 2015-03-19 2020-02-18 Daiichi Sankyo Company, Limited Solid preparation including antioxidant
FR3075662B1 (fr) * 2017-12-21 2022-06-24 Ifp Energies Now Procede de pretraitement pour ameliorer le remplissage d'une enceinte avec des particules solides
CN111971036A (zh) * 2018-07-30 2020-11-20 第一三共株式会社 含有稳定剂的固体药物制剂
EP4082536A4 (fr) 2019-12-23 2024-01-24 Daiichi Sankyo Company, Limited Comprimés pelliculés ayant une surface lisse
KR20230044355A (ko) 2020-07-27 2023-04-04 다이이찌 산쿄 가부시키가이샤 미로가발린베실산염을 함유하는 구강내 붕괴정

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3928183A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Lactamfreie cyclische aminosaeuren
JPH11189547A (ja) * 1997-12-26 1999-07-13 Taisho Pharmaceut Co Ltd 安定化されたニコランジル製剤及びその製造方法
JP2001064177A (ja) * 1999-08-16 2001-03-13 Schering Ag ベンズアミド誘導体を有効成分とする製剤
GB0425955D0 (en) * 2004-11-25 2004-12-29 Pfizer Ltd Salt form
WO2006056874A1 (fr) * 2004-11-25 2006-06-01 Pfizer Limited Forme saline
JP4691434B2 (ja) * 2005-11-08 2011-06-01 東和薬品株式会社 安定化されたカベルゴリン固形製剤
EP2657219B1 (fr) * 2007-09-28 2014-12-10 Daiichi Sankyo Company, Limited Intermédiaire pour produire un dérivé d'acide y-amino bicyclique
EP2327424A4 (fr) * 2008-08-18 2014-10-01 Mitsubishi Shoji Foodtech Co Ltd Nouvel excipient pour la fabrication de comprimés de mannitol
JP2010241796A (ja) * 2009-03-17 2010-10-28 Daiichi Sankyo Co Ltd 二環性γ−アミノ酸誘導体含有医薬組成物
WO2010110361A1 (fr) * 2009-03-26 2010-09-30 第一三共株式会社 Méthode de production d'un dérivé d'acide γ-aminé bicyclique
JP5674666B2 (ja) * 2009-08-11 2015-02-25 富士化学工業株式会社 崩壊性粒子組成物及び口腔内速崩壊錠

Also Published As

Publication number Publication date
CA2870675A1 (fr) 2014-10-09
EP2826477A4 (fr) 2015-09-09
JP5627062B1 (ja) 2014-11-19
TWI645863B (zh) 2019-01-01
CA2870675C (fr) 2017-03-28
EP2826477B1 (fr) 2017-05-31
ES2638420T3 (es) 2017-10-20
IN2014MN02116A (fr) 2015-09-04
CN104334169A (zh) 2015-02-04
BR112014029538A2 (pt) 2017-06-27
US20150079166A1 (en) 2015-03-19
BR112014029538B1 (pt) 2022-07-05
KR20150138800A (ko) 2015-12-10
JPWO2014163132A1 (ja) 2017-02-16
KR102142257B1 (ko) 2020-08-07
CN104334169B (zh) 2016-11-02
US9675570B2 (en) 2017-06-13
TW201517932A (zh) 2015-05-16
WO2014163132A1 (fr) 2014-10-09
EP2826477A1 (fr) 2015-01-21

Similar Documents

Publication Publication Date Title
HK1245769B (zh) 作為jak抑制劑的聯吡唑鹽
HUE056378T2 (hu) R-Ketamin és sójának alkalmazása gyógyszerekként
HUE045982T2 (hu) S-Ketamin-hidroklorid gyógyászati kompozíció
HK1225372A1 (zh) 氨基酸衍生物
HK1214255A1 (zh) -醯基氨基噻唑衍生物或其鹽
HK1204559A1 (en) Solid composition of amino carboxylate salt
IL243829A0 (en) Production method for saline preparation
GB201208293D0 (en) Hydrochlorice salt of peptide
HK1248224A1 (zh) 作為阿片激動劑的α-6-MPEG6-O-羥基可酮的固體鹽形式以及其用途
HRP20182110T1 (hr) Sastav spojeva tiakumicina
HK1204865A1 (en) Composition for elimination of troublesome varmints
IL245452A0 (en) Salts of Armachol